CPR3 awards $6+ million to more than 30 UC-based teams for pandemic resiliency research
Learn more below about this important investment in public health research

UC-CDPH Collaborative Awards More Than $6 Million for Pandemic Resiliency Research 

San Francisco (September 20, 2023) – More than 30 research projects led by teams from all 10 University of California (UC) campuses have been awarded over $6 million in funding from the CPR3 program – the California Collaborative for Pandemic Recovery and Readiness Research. CPR3 is a joint effort between UC San Francisco (UCSF), the California Health and Human Services Agency (CalHHS), and the California Department of Public Health (CDPH), aimed at using real-world evidence from the effects of the COVID-19 pandemic to help all Californians gain a renewed and improved sense of health and wellbeing. Read more


Portfolio Kickoff Event Launches CPR³ Network

CPR³'s portfolio kickoff meeting brought together funded teams, community partners, and policy and public health stakeholders. Guest speakers who framed the initiative and its priority areas included: Tomás Aragon (CDPH), Rohan Radhakrishna (CDPH Office of Health Equity), Stephanie Welch (CalHHS), Melissa Stafford Jones (CalHHS), and Erica Pan (CDPH). A member from each awarded team presented a visual abstract of their project, highlighting the overall goal and evidence gap they hope to fill. We were thrilled to officially launch this collaborative and look forward to continuing the dialogue surrounding these projects! Watch the recording here.


UC Launches Research Initiative on Pandemic Recovery and Readiness

San Francisco (December 12, 2022) – The University of California, San Francisco (UCSF) launched the California Collaborative for Pandemic Recovery and Readiness Research (CPR3), a research initiative to investigate the effects of the pandemic on California communities and individuals. The new research program aims to leverage lessons learned from the COVID-19 pandemic to inform future public health policies and investments. The research is led by Principal Investigator Dr. Priya Shete, Associate Professor of Medicine and Epidemiology at UCSF. Read more.